Atlas Trials

A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC

Clinical trial NCT06443684 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06443684
Sponsor
Shanghai Chest Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Non Small Cell Lung Cancer
Start date
2023-05-08
Primary completion
2026-12-07
Enrollment
305

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.